BofA raised the firm’s price target on Alignment Healthcare to $10 from $8.50 and keeps a Neutral rating on the shares. In “a positive surprise,” Alignment now expects to expand MA membership greater than 40% in 2024, says the analyst, who thinks these “impressive results help address some lingering concerns about growth targets.” However, the firm reiterates a Neutral rating as it waits for more data on utilization trends in 2024.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on ALHC:
- Alignment Healthcare Delivers 44% Year-Over-Year Membership Growth Following Significant Boost from AEP, Increasing Membership to 155,500
- Alignment Healthcare to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
- Alignment Healthcare price target raised by $1.25 at BofA, here’s why
- Alignment Healthcare, musician Luis Miguel partner for campaign
